Metal Complexes for Imaging and Therapy
A special issue of Inorganics (ISSN 2304-6740). This special issue belongs to the section "Bioinorganic Chemistry".
Deadline for manuscript submissions: closed (15 November 2017)
Special Issue Editors
Interests: inorganic chemistry; medicinal chemistry; radiopharmaceutical chemistry; nuclear medicine; nanomedicine
Interests: molecular imaging; nuclear chemistry; radiopharmaceutical chemistry; theranostics; metallodrugs; peptides; targeted radionuclide therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The design of novel metal-based compounds plays an important role in the development of innovative drugs for diagnostic or therapeutic applications. Such compounds present a set of intrinsic advantages related to their structural diversity and unique magnetic, radiochemical, and electrochemical properties. Indeed, metal complexes have emerged in the past few years as very versatile tools to develop new cytotoxic drugs for cancer therapy, radiopharmaceuticals for nuclear imaging or radionuclide therapy and contrast agents for magnetic resonance imaging, just to mention a few representative examples. The physicochemical properties of the complex itself are key to obtain the desired imaging/therapeutic effects, whereas its functionalization with specific biomolecules is of great importance to achieve target organ/tissue-preferential accumulation, taking advantage from the advances in bioconjugation strategies and chemical biology. This Special Issue of Inorganics will focus on the most relevant chemical aspects and biological features of important classes of metallodrugs, i.e.,:
- Cytotoxic drugs for anticancer therapy
- Radiopharmaceuticals for molecular imaging and theranostics
- Contrast agents for magnetic resonance imaging (MRI)
- Photosensitizers for photodynamic therapy (PDT)
- CO releasing molecules (CORMs) for therapeutic applications
We are convicted that this Special Issue will contribute to awake the inorganic chemistry community for the role of metal-based compounds within biomedical applications. Thus, we would be very glad if you consider contributing to this issue by submitting an article (review, research paper or communication) in one of the topics referred above. We expect your work to be inspiring to other scientists in the field, which will certainly flourish in the next years, with positive impact in the rise of molecular and personalized medicine.
Prof. Dr. António Paulo
Prof. Dr. João D. G. Correia
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Inorganics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Metallodrugs
- Cytotoxic Agents
- Radiopharmaceuticals
- Contrast Agents
- Photosensitizers
- CORMs
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
